Article

Congress passes legislation regarding military members with eye trauma

Washington, DC-Congress has approved legislation to improve the Department of Defense's (DoD) and the Veterans Health Administrations' (VHA) ability to treat those who have incurred serious eye injures while on active duty.

Washington, DC-Congress has approved legislation to improve the Department of Defense's (DoD) and the Veterans Health Administrations' (VHA) ability to treat those who have incurred serious eye injures while on active duty.

Also, as a part of the National Defense Authorization Act, a center of excellence will be established within the DoD to improve the tracking, diagnosis, treatment, and follow-up for service members who already have had severe eye injuries.

The measure is expected signed by President Bush as soon as today.

Joined with the Blinded Veterans Association and other veterans' service organizations, the American Academy of Ophthalmology (AAO) expressed support of the legislation, which also will create a formal registry housing electronic records, enabling the DoD and Department of Veterans Affairs (VA) to share patient information.

"We want to ensure that active duty members and veterans of prior service are provided with excellent eye care and resources," said James C. Orcutt, MD, PhD, chief ophthalmology consultant for the VHA and a member of the AAO. "The establishment of a registry that will allow us to track veterans and active duty personnel who have eye injuries significantly enhances our ability to meet that goal. In addition, the ability of the DoD and VA to work hand in hand on eye injury cases will benefit both active duty troops and veterans."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.